CAAP Company: CMAX Technologies Joint Venture Partner BlueOcean NutraSciences Inc. Announces World’s first Omega-3 Oils in XR Tablet Form

BlueOceanNutraSciences Inc. (TSXV:BOC) announced that it has received a Natural Products Number (NPN) from Health Canada for its extended release Omega-3 astaxanthin shrimp oil tablets (“XR tablets”), the World’s first Omega-3 oils in XR tablet form.

The Company’s shrimp oil XR tablets were developed by its joint venture partner, CMAX Technologies Inc. (“CMAX”).

The Health Canada NPN number was a long time coming as we were the first company to make an XROmega-3 product. Their approval further legitimizes our XR shrimp oil product and we can now begin marketing and selling this new high bioavailability XR Omega-3 oil nutrient delivery system in Canada.
— Dr. Marvin Heuer, CEO, BlueOcean NutraSciences

See the press release here